Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-cash Items (2020 - 2023)

Historic Non-cash Items for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $3.3 million.

  • Terns Pharmaceuticals' Non-cash Items rose 3831.38% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 3831.38%. This contributed to the annual value of $2.5 million for FY2022, which is 9112.61% down from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Non-cash Items of $3.3 million as of Q3 2023, which was up 3831.38% from $3.1 million recorded in Q2 2023.
  • Terns Pharmaceuticals' Non-cash Items' 5-year high stood at $35.3 million during Q1 2023, with a 5-year trough of $2.0 million in Q1 2021.
  • Its 4-year average for Non-cash Items is $17.5 million, with a median of $23.4 million in 2022.
  • Over the last 5 years, Terns Pharmaceuticals' Non-cash Items had its largest YoY gain of 131293.88% in 2022, and its largest YoY loss of 9232.22% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Non-cash Items (Quarter) stood at $26.7 million in 2020, then increased by 7.12% to $28.6 million in 2021, then dropped by 25.87% to $21.2 million in 2022, then crashed by 84.47% to $3.3 million in 2023.
  • Its Non-cash Items stands at $3.3 million for Q3 2023, versus $3.1 million for Q2 2023 and $35.3 million for Q1 2023.